BG104682A - Liquid pharmaceutical formulation containing zotepine - Google Patents

Liquid pharmaceutical formulation containing zotepine

Info

Publication number
BG104682A
BG104682A BG104682A BG10468200A BG104682A BG 104682 A BG104682 A BG 104682A BG 104682 A BG104682 A BG 104682A BG 10468200 A BG10468200 A BG 10468200A BG 104682 A BG104682 A BG 104682A
Authority
BG
Bulgaria
Prior art keywords
acid
zotepine
pharmaceutical formulation
liquid pharmaceutical
formulation containing
Prior art date
Application number
BG104682A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ann DYER
Alan Smith
Original Assignee
Knoll Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft
Publication of BG104682A publication Critical patent/BG104682A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG104682A 1998-02-07 2000-08-09 Liquid pharmaceutical formulation containing zotepine BG104682A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation
PCT/EP1999/000533 WO1999039709A1 (en) 1998-02-07 1999-01-27 Liquid pharmaceutical formulation containing zotepine

Publications (1)

Publication Number Publication Date
BG104682A true BG104682A (en) 2001-05-31

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104682A BG104682A (en) 1998-02-07 2000-08-09 Liquid pharmaceutical formulation containing zotepine

Country Status (25)

Country Link
US (1) US6239165B1 (xx)
EP (1) EP1054666B1 (xx)
JP (1) JP2002502818A (xx)
KR (1) KR20010040717A (xx)
AR (1) AR018062A1 (xx)
AT (1) ATE227988T1 (xx)
AU (1) AU2720099A (xx)
BG (1) BG104682A (xx)
BR (1) BR9907644A (xx)
CA (1) CA2320475A1 (xx)
CO (1) CO4970815A1 (xx)
CZ (1) CZ291975B6 (xx)
DE (1) DE69904021T2 (xx)
DK (1) DK1054666T3 (xx)
ES (1) ES2188135T3 (xx)
GB (1) GB9802617D0 (xx)
HK (1) HK1033088A1 (xx)
HR (1) HRP20000579A2 (xx)
HU (1) HUP0100769A3 (xx)
PL (1) PL342213A1 (xx)
PT (1) PT1054666E (xx)
SK (1) SK11472000A3 (xx)
TR (1) TR200002288T2 (xx)
WO (1) WO1999039709A1 (xx)
ZA (1) ZA99918B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247067A (en) * 1968-02-16 1971-09-22 Fujisawa Pharmaceutical Co Tricyclic enol ether compounds and the preparation thereof
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) * 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
IL117612A0 (en) * 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine
GB9526264D0 (en) * 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
HUP0100769A2 (hu) 2001-12-28
EP1054666A1 (en) 2000-11-29
SK11472000A3 (sk) 2001-08-06
BR9907644A (pt) 2000-11-14
US6239165B1 (en) 2001-05-29
ZA99918B (en) 2000-08-07
CZ20002846A3 (cs) 2000-12-13
ES2188135T3 (es) 2003-06-16
KR20010040717A (ko) 2001-05-15
TR200002288T2 (tr) 2000-12-21
WO1999039709A1 (en) 1999-08-12
HRP20000579A2 (en) 2001-04-30
HK1033088A1 (en) 2001-08-17
DE69904021D1 (de) 2003-01-02
HUP0100769A3 (en) 2002-04-29
CA2320475A1 (en) 1999-08-12
AU2720099A (en) 1999-08-23
CO4970815A1 (es) 2000-11-07
EP1054666B1 (en) 2002-11-20
GB9802617D0 (en) 1998-04-01
ATE227988T1 (de) 2002-12-15
DK1054666T3 (da) 2003-03-17
PT1054666E (pt) 2003-03-31
DE69904021T2 (de) 2003-04-30
AR018062A1 (es) 2001-10-31
CZ291975B6 (cs) 2003-06-18
JP2002502818A (ja) 2002-01-29
PL342213A1 (en) 2001-05-21

Similar Documents

Publication Publication Date Title
CA2402431A1 (en) 1,2,3,4-tetrahydroisoquinoline derivatives
IL157933A (en) Tetratrate salts of 14,8,5-triazate tetracyclo [9,04.11,02.1.3.10] - Hexadka @ - @@@@@@@@@@@@@ - Penta-An @ and pharmaceuticals containing them
MXPA03001169A (es) Biciclo-pirazoles activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que comprenden los mismos.
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
CA2361402A1 (en) Bis-sulfonamides
HK1002017A1 (en) Lyospheres comprising gonadotropin
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
PL344042A1 (en) Compounds with growth hormone releasing properties
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
CA2132475A1 (en) A process for cleaning and disinfecting devices in the brewing industry
SI1407763T1 (sl) Sestavki, ki vsebujejo kozmeticno aktivno organsko kislino in zelenjavni produkt
AP2002002522A0 (en) Citrate salt of 5,8,14-triazatetracyclo Ä10.3.02,11.04,9Ü-hexadeca-2 (11),3,5,7,9-pentaene and pharmacetical compositions thereof
WO2002024697A1 (fr) Composes spiro et inhibiteurs de molecules d'adhesion contenant ces composes comme ingredient actif
MA21531A1 (fr) Compositions antifougique symergique contenant de l'imazalil et du propieon azole, procede pour sa preparation et procede de lutte contre les champignons l'utilisant .
CA2429639A1 (en) Stable azithromycin monohydrate
IL111252A0 (en) Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient,and intermediate compound for use in production of said dihalopropene compound
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
WO2002024665A8 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
EP1133979A3 (fr) Utilisation de corps gras particuliers permettant de modifier les propriétés physico-chimiques de la peau et/ou des muqueuses en tant qu'agents empêchant ou diminuant l'adhésion des micro-organismes sur ces dernières
WO2002008222A3 (en) HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
CA2220019A1 (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
IL137794A0 (en) Streptogramin derivatives, preparation method and compositions containing same
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
WO2001009122A3 (en) Serotonergic benzofurans
BG104682A (en) Liquid pharmaceutical formulation containing zotepine